Notice Number: NOT-OD-08-017
Release Date: November 28, 2007
National Institutes of Health (NIH), (http://www.nih.gov)
A recent open letter to Secretary Leavitt from Dr. Roland Nardone and several experts in cell biology highlighted an important methodological issue associated with research involving cultured cells. The letter identifies a number of instances in which research has been based on misidentified or contaminated cultures. In some cases, proper characterization would have altered the experimental outcome significantly. Improper characterization can impede efforts to replicate published findings and therefore the advancement of science. The letter goes on to indicate that there are relatively inexpensive ways to authenticate lines and characterize these experimental systems. Dr. Nardone recommends that granting agencies restrict funding to institutions that do not use available authentication procedures.
We are convinced by the body of evidence developed by Dr. Nardone and his colleagues that misidentification of cell cultures is a serious problem 1. Because authentication methods can be quite specific and are continuously evolving, it would be impractical for the NIH to require application of particular methods in all grant applications. The peer review process has been designed to carefully examine the experimental approach and assure that the investigators propose appropriate methods and resources for the described study. A similar process is used to screen manuscripts for publication. Both review processes can accommodate improvements in methodologies and experimental systems in ways that would be difficult for the segments of a granting agency involved in making awards.
We believe that professional societies, researchers, and reviewers are continually working to establish a range of acceptable experimental practices. Grant applications that fail to employ such practices would not be considered of the highest quality and such manuscripts would not fare well in the journal review process. We encourage all reviewers to consider these issues carefully in order to protect and promote the validity of the science we support.
Norka Ruiz Bravo, Ph.D.
NIH Deputy Director for Extramural Research
Michael Gottesman, M.D.
NIH Deputy Director for Intramural Research
For further information contact Walter T. Schaffer, Ph.D., Senior Scientific Advisor for Extramural Research, Building One, Room 144, Bethesda, Maryland 20892
Phone 301-402-2725, Email: firstname.lastname@example.org
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.